HuGE Literature Finder
Records
1
-
6
Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes. Gene 2020 Feb 737 144435. Babteen Nouf Abubakr, Fawzy Manal S, Alelwani Walla, Alharbi Raed A, Alruwetei Abdulmohsen M, Toraih Eman A, Elshazli Rami |
SNP-SNP interactions of immunity related genes involved in the CD28/B7 pathway with susceptibility to invasive ductal carcinoma of the breast. Gene 2015 Jul 566 (2): 217-22. Zhifu Yu, Mingli Jiao, Shuang Chen, Fan Wang, Zhenkun Fu, Wangyang Chen, Lin Zhu, Guangxiao Li, Yashuang Zhao, Dianjun |
Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2014 Oct 16 (10): 879-85. Zhao H-Y, Duan H-X, Gu |
Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis. PloS one 2013 8 (12): e83710. Yan Qing, Chen Pin, Lu Ailin, Zhao Peng, Gu Aih |
Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer genetics and cytogenetics 2006 Mar 165 (2): 114-20. Erfani N, Razmkhah M, Talei A R, Pezeshki A M, Doroudchi M, Monabati A, Ghaderi |
Association of CTLA4 and CD28 Gene Variants and Circulating Levels of Their Proteins in Patients with Breast Cancer. In vivo (Athens, Greece) 0 30 (4): 485-493. Isitmangil Gulbu, Gurleyik Gunay, Aker Fugen Vardar, Coskun Cihan, Kucukhuseyin Ozlem, Arikan Soykan, Turan Saime, Talu Canan Kelten, Dogan Mehmet Baki, Farooqi Ammad Ahmad, Yaylim Ilh |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: